Atherectomy Devices Market by Product (Rotational Atherectomy Systems, Directional Atherectomy Systems, Orbital Atherectomy Systems, Photo-Ablative (Laser) Atherectomy Systems, and Support Devices), Application (Cardiovascular, Peripheral Vascular, and Neurovascular), and End User (Hospitals and Surgical Centers, Ambulatory Surgical Centers, and Others): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026792 | Pages: 100 | Industry: Medical Device | Date: Oct 2022 | Type: Global

The market crossed US$ 1280.00 million mark in 2022 and is expected to hit US$ 2330.00 million by 2030, recording a CAGR of 7.70% during the forecast period.

Growing preference for minimal invasive surgeries result in high adoption of atherectomy devices.

The rising preference for minimally invasive surgeries to remove plaque build-up in the arteries, drives the market growth. The demand for minimally invasive surgery is increasing at a very high rate due to several factors, such as less pain, reduced complications, shorter hospital stay, less scarring and tissue injury, and increased accuracy rate. In addition, atherectomy devices provide distinct advantage in the removal of atherosclerotic lesions without the involvement of implantable devices such as the stents. It also helps in avoiding disadvantages associated with surgical procedures, such as surgical scarring and inflammation after stent implantation. Therefore, the advantages offered by atherectomy devices are expected to support the growth of the market. Moreover, the directional atherectomy systems segment is expected to pace up owing to rising availability of reimbursements for vascular treatment procedures across developed countries, high preference for minimally invasive procedures among medical professionals, clinical benefits offered by these devices, and ongoing technology advancements in the field of directional atherectomy. The plaque removal via directional atherectomy may produce an angiographic result that is superior as compared to the result obtained by percutaneous transluminal coronary angioplasty.

Within the report, the market is segmented into product, application, end user, and geography. By product, the market is further segmented into rotational atherectomy systems, directional atherectomy systems, orbital atherectomy systems, photo-ablative (laser) atherectomy systems, support devices. By application, the market is categorized into cardiovascular, peripheral vascular, and neurovascular. Based on end user, the market is divided into hospitals and surgical centers, ambulatory surgical centers, and others. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Increasing CVD cases to surge the demand of the atherectomy devices.

Atherectomy is a surgical procedure performed to treat atherosclerosis and peripheral artery disease in the lower extremities in order to remove plaque build-up in the arteries without affecting the rest vessel wall. Atherectomy devices are effectively used in the treatment of coronary and peripheral arterial diseases. These devices are designed differently to cut, shave, sand, or vaporize plaques, depending on their characteristics. Moreover, increasing incidences of cardiovascular diseases (CVDs) is due to use of Tobacco, unhealthy diet, and physical inactivity may lead to increase in demand for atherectomy devices for the treatment of CVDs. For instance, according to research published by World Health Organization (WHO) in 2021, around 17.9 million people died from CVD in 2019, representing 32% of all global deaths. Among these deaths, 85% were due to heart attack and stroke. According to study published in Heart Foundation in 2020, on average, 118 Australians die from CVD each day, or one person every 12 minutes. This represents 16.6% of the total Australian population living with CVD. Some of the CVD includes, myocardial infarction and other conditions, and atherosclerosis is considered to be a major cause behind myocardial infarction. Thus, in order to treat the rising condition, the atherectomy devices are used, which in turn will increase the demand of the product in the forecast period.

 

North America is expected to hold the largest share of the market.

The market is expected to grow in North America owing to increasing availability of reimbursement policies for atherectomy systems, adoption of atherectomy systems among medical professionals, huge patient population of peripheral and coronary artery diseases, and an increasing number of clinical trials. In the US, CVD accounted for approximately 18.6 million deaths in 2019, as per the American Heart Association. It creates a burden on the country’s healthcare system, because of which, the demand for atherectomy devices is anticipated to increase during the forecast period. Furthermore, suitable reimbursement scenario and a high number of FDA-approved devices also favor the growth of the market. For instance, in April 2019, Avinger Inc. received FDA 510(K) clearance for the Pantheris SV image-guided atherectomy system, which is expected to increase the company’s share in the atherectomy devices market..

 

Recent strategic developments in atherectomy devices market

The atherectomy devices market has undergone several significant developments, and a few of these have been mentioned below:

  • In September 2020, AngioDynamics, Inc. launched the Auryon Atherectomy System, a newly developed innovative technology for the treatment of peripheral artery disease (PAD), including critical limb ischemia (CLI) and in-stent restenosis (ISR). The system is the first laser atherectomy system to efficiently treat lesions of any type, length, or location, with minimal impact on vessel walls.
  • In January 2021, Cardiovascular Systems (CSI) secured CE mark approval for the Diamondback 360 coronary orbital atherectomy system (OAS) and ViperWire Advance coronary guide wire with flex tip (ViperWire Advance with flex tip). It integrates differential sanding and pulsatile forces to treat all calcium modalities, including nodular, eccentric (irregular) and concentric (ring-shaped).
  • In August 2021, Medtronic revived old product line to increase offerings for atherectomy devices. The FDA announced the successful 510(k) application of Medtronic’s TurboHawk Plus Directional Atherectomy System, which the company is using to support market growth outside of the US.

The atherectomy devices market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Medtronic; Boston Scientific Corporation; Abbott; Cardiovascular Systems, Inc.; Philips; AngioDynamics; and CR Bard are among the prominent players operating in the market.

Target audience for the report:

  • Raw material providers
  • Atherectomy devices-related associations, organizations, forums, and alliances
  • Government bodies, such as regulating authorities and policy makers
  • Venture capitalists, private equity firms, and start-up companies
  • Distributors and sales firms in atherectomy devices
  • End users of devices
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented based on:

  • Product:
    • Rotational Atherectomy Systems
    • Directional Atherectomy Systems
    • Orbital Atherectomy Systems
    • Photo-Ablative (Laser) Atherectomy Systems
    • Support Devices
  • Application:
    • Cardiovascular
    • Peripheral Vascular
    • Neurovascular
  • End User:
    • Hospitals and Surgical Centers
    • Ambulatory Surgical Centers
    • Others
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • Medtronic
    • Boston Scientific Corporation
    • Abbott
    • Cardiovascular Systems, Inc.
    • Philips
    • AngioDynamics
    • CR Bard
    • Straub Medical AG.
    • Avinger
    • Biotronik.

The List of Companies
- Medtronic
- Boston Scientific Corporation
- Abbott
- Cardiovascular Systems, Inc.
- Philips
- AngioDynamics
- CR Bard
- Straub Medical AG.
- Avinger
- Biotronik.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$2000
Site License
$3000
Enterprise License
$4000